Sector: Diversified FMCG - Fast Moving Consumer Goods
BSE Code: 544279
NSE Symbol: GODAVARIB
ISIN: INE497S01012
🏆 Godavari Biorefineries Sets New Crushing Record: 2.5M Tonnes • Record sugarcane crushing: 2.5 million tonnes • Achieved during 25-26 crushing session • Highest crushing volume in company history for a single session • Crushing conducted at Sameerwadi unit • Session scheduled to end on April 7, …
📅 Godavari Biorefineries Ltd Announces Investor & Analyst Meeting on April 9, 2026 • Godavari Biorefineries Ltd (Script: GODAVARIB, ISIN: INE497S01012) will hold a group meeting with investors and analysts • The meeting will take place on Thursday, April 9, 2026 • The meeting will be conducted in…
📈 Godavari Biorefineries FY25: 11% Revenue Growth, Margin Contraction & Expansion Plans • Total operating income grew 11% YoY to ₹1,870.25 crore in FY25 • PBILDT margin contracted to 5.55% in FY25 from 7.93% in FY24 • Grain-based distillery expansion of 200 KLPD capacity underway, commissioning e…
Godavari Biorefineries Plans ₹325 Cr Expansion, Targets 3x EBITDA Growth by FY29 📈 • Planned capital expenditure of ₹325 crores by FY29 • 75% of capex allocated to bio-based chemicals expansion • 25% of capex allocated to ethanol capacity expansion • Grain-based ethanol distillery commissioning p…
🎧 Godavari Biorefineries Q3 & 9M FY26 Earnings Call Recording Now Available - Godavari Biorefineries Ltd (Symbol: GODAVARIB, Code: 544279) uploaded the Q3 and 9M FY26 earnings conference call recording. - The recording is accessible on the company's official website: https://www.godavaribiorefine…
Godavari Biorefineries Q3 FY26 Results: Revenue Up 2.5% 📊 | New Ethanol Plant Coming in FY27 🏭 • Q3 FY26 consolidated revenue: ₹461.9 crores (2.5% YoY growth) • Bio-based chemicals revenue: ₹142.3 crores (3.8% YoY growth) with 76.7% EBITDA growth • Ethanol segment revenue: ₹132.3 crores (23.6% Y…
Godavari Biorefineries IPO Update: ₹325 Cr Utilization Report 📊 • Final monitoring report submitted for ₹325 crore IPO covering quarter ended December 31, 2025 • Minor deviation of ₹0.09 crore (0.03%) in funds transferred to monitoring account • ₹3.37 crore reclassified from issue expenses to gen…
Godavari Biorefineries Q3 2025 Results: Revenue Up, Returns to Profit 📊 • Consolidated Q3 2025 revenue: ₹45,985.25 lakhs (up from ₹43,075.08 lakhs in Q2 2025) • Q3 2025 profit after tax: ₹825.24 lakhs (vs. loss of ₹4,159.24 lakhs in Q2 2025) • Sugar segment revenue highest at ₹33,957.88 lakhs in …
Godavari Biorefineries Q3 FY26: Revenue Up 2.5% 📈 | Jivana Brand Hits ₹100 Cr Milestone 🎯 • Q3 FY26 total income: ₹461.9 crore, up 2.5% year-on-year • EBITDA margin improved to 9.8% from 8.8% • PBT before exceptional items surged 152.2% to ₹21.4 crore • Bio-based chemicals segment EBITDA grew 76…
📊 Godavari Biorefineries Q3 2025 Results: Revenue & Loss Insights • Consolidated Q3 2025 revenue: ₹45,985.25 lakhs • Nine-month consolidated revenue: ₹142,383.96 lakhs • Standalone Q3 2025 revenue: ₹45,608.15 lakhs • Consolidated Q3 net loss: ₹25.21 lakhs • Nine-month consolidated net loss: ₹8,71…
Godavari Biorefineries Receives NGT Directive on Environmental Measures 🏭💧 • National Green Tribunal (NGT) issued an order to Godavari Biorefineries Ltd on February 09, 2026 • Order follows a complaint filed on March 24, 2024 alleging water and air pollution from the Sakarwadi facility • Company…
🌱 Godavari Biorefineries & Synthomer Partner to Develop Bio-Based Monomer Alternatives • Godavari Biorefineries Limited (GBL) partners with Synthomer to develop bio-based alternatives to fossil-based monomers. • Synthomer will commercialize bio-based butyl acrylate using bio-based butanol produce…
📊 Godavari Biorefineries Ltd Q3 & 9M FY26 Earnings Call on Feb 19 - Earnings conference call scheduled for February 19, 2026, at 11:00 AM IST. - Discussion will cover Q3 and 9-month FY26 financial and operational performance. - Key speakers include Mr. Samir Somaiya (Chairman & Managing Director)…
Godavari Biorefineries Shares Surge: What’s Behind the Rally? 📈 - Company confirms compliance with SEBI Listing Regulations, including all necessary disclosures. - No undisclosed or price-sensitive information pending disclosure to stock exchanges. - Unaware of the reason for the significant incr…
Godavari Biorefineries Launches US Subsidiary for Cancer Drug Discovery 🎯💊 - Godavari Biorefineries Ltd (GBL) establishes Sathgen Therapeutics LLC, a US-based subsidiary focused on drug discovery. - Sathgen will specialize in triple-negative breast cancer (TNBC) and other aggressive cancers. - D…
🚀 Godavari Biorefineries Secures US Patent for Promising Cancer Treatment Compounds - US Patent No. US 12,459,930 B2 granted for 'COMPOUNDS FOR THE INHIBITION OF UNREGULATED CELL GROWTH'. - Covers novel chemical compounds, synthesis process, and biological activity against cancer stem cells. - Sh…
🚀 Godavari Biorefineries Reports Strong Growth & Strategic Expansions in Q2 FY26 - Revenue from operations grew 34% YoY to ₹430.8Cr in Q2 FY26. - EBITDA loss reduced to ₹4.4Cr (vs ₹31.5Cr loss in Q2 FY25). - Bio-based chemicals EBITDA surged 60% on better realizations & specialty crops. - Ethanol…
Godavari Biorefineries Expands into US Pharma Market with New Subsidiary 💊🌎 - Godavari Biorefineries Ltd established Sathgen Therapeutics, LLC in the USA on November 17, 2025. - The new subsidiary focuses on pharmaceutical marketing with a share capital of US$ 350,000. - Sathgen will drive busin…
📈 GBL’s Growth & Sustainability Push: 11% Revenue Rise, 40% Emissions Cut, and Strategic Expansions - Revenue grew 11% to ₹1,853 Cr in FY 2024-25, though a deferred tax expense led to a net loss of ₹27 Cr (underlying loss: ₹2.67 Cr post-adjustment). - Sugar segment surged 26% (₹682 Cr) on record …
🌱 Godavari Biorefineries Releases FY 2024-25 Sustainability Report - Godavari Biorefineries Ltd has published its Sustainability Report for the Financial Year 2024-25. - The report is accessible on the company's website: [https://www.godavaribiorefineries.com/sites/default/files/Sustainability_Re…